Trials
All clinical studies
Read about our projects
-
SPCG 19/ Get-Randomized- Prostate (Grand-P): A randomized, multi-center trial of immediate curative therapy compared with standard conservative treatment in older men aged ≥ 75 years with non-metastatic, high-risk prostate cancer
See details -
Prostate Cancer Active Surveillance Trigger Trial (PCASTT)
See details -
No information available
See details -
Primary radical prostatectomy versus primary radiotherapy for locally advanced prostate cancer: an open randomized clinical trial
See details -
SPCG-14 (SPCG-14 PSA-ERECT M0)
A Randomized, Open Label, Multicenter, Phase III, 2-Arm Study of Androgen Deprivation ± Docetaxel for Non-metastastic Prostate Cancer Patients with a Rising PSA
See details -
A Randomized phase III trial of six cycles of docetaxel versus surveillance plus hormonal treatment after radical radiotherapy in patients with intermediate or high-risk prostate cancer (SPCG-13 AdRad)
See details -
An open randomised phase III trial of six cycles of docetaxel versus surveillance after radical prostatectomy in prostate cancer patients with high grade pT3 or margin positive pT2
See details -
Effectiveness of Zometa® treatment for the prevention of bone metastases in high risk prostate cancer patients. A randomized, open-label, multicenter study of the European Association of Urology (EAU) in cooperation with the Scandinavian Prostate Cancer Group (SPCG) and the Arbeitsgemeinschaft Urologische Onkologie (AUO)
See details -
Randomised trial comparing radical prostatectomy versus radiotherapy plus protocol on follow-up of non-randomised patients with localised prostate cancer
See details -
Antiandrogen followed by TAB on biochemical progression versus TAB
See details -
An open pilot study evaluating intermittent androgen suppression in patients with advanced prostate cancer
See details -
Institution of second-line Estracyt therapy at an increase in PSA values for metastatic prostate cancer
See details -
Post-treatment Prostatic Biopsies after Antiandrogen treatment with or without Radiotherapy
See details -
Randomized trial of locally advanced prostate cancer. Antiandrogen treatment with or without radiotherapy
See details -
A randomized, double-blind, parallel-group trial comparing Casodex 150 mg once daily with placebo in patients with non-metastatic prostate cancer
See details